Get the Stockscreener App
22.27
0.13%
0.03
After Hours:
22.27
Integra Lifesciences Holdings Corp stock is traded at $22.27, with a volume of 570.37K.
It is up +0.13% in the last 24 hours and down -8.20% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$22.24
Open:
$22.2
24h Volume:
570.37K
Relative Volume:
0.97
Market Cap:
$1.73B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
44.54
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+1.09%
1M Performance:
-8.20%
6M Performance:
+27.48%
1Y Performance:
-37.76%
1-Day Range:
$22.12
$22.73
1-Week Range:
$21.77
$24.36
52-Week Range:
$16.80
$35.91
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
22.27 | 1.73B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra LifeSciences to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - Yahoo Finance
Integra LifeSciences Holdings Corp. to Host Earnings Call - ACCESS Newswire
Amalgamated Bank Has $440,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - SETE News
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Trading Up 5.1%Time to Buy? - MarketBeat
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Investor Network: INTEGRA LIFESCIENCES HOLDINGS CORP to Host Earnings Call - ACCESS Newswire
Integra LifeSciences Holdings Corp Releases 2024 Form 10-K Report: A Comprehensive Analysis of Financial Performance, Business Strategy, and Market Challenges - HPBL
Integra LifeSciences maintains $35 target, Market Outperform rating By Investing.com - Investing.com South Africa
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Call Highlights: Strong Revenue ... - Yahoo Finance
INTEGRA LIFESCIENCES HOLDINGS CORP SEC 10-K Report - TradingView
Integra LifeSciences (IART) Stock Rises on Strong Q4 Results - GuruFocus.com
Integra LifeSciences Stock Surges 13.6% Post Q4 2024 ResultsNews and Statistics - IndexBox, Inc.
Integra: Q4 Earnings Snapshot - The Washington Post
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2024 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Integra LifeSciences Q4 2024 EPS beats, stock rises - Investing.com
Integra LifeSciences Guides FY25 In Line With View; Q4 Adj. EPS Tops Estimates - Nasdaq
INTEGRA LIFESCIENCES HLDGS Earnings Results: $IART Reports Quarterly Earnings - Nasdaq
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView
Integra LifeSciences (NASDAQ:IART) Misses Q4 Revenue Estimates - Yahoo Finance
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance - Yahoo Finance
Integra Lifesciences Q4 2024 Earnings: EPS Misses at $0.25, Reve - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Repor - GuruFocus.com
Integra Lifesciences Holdings Corp (IART) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance
INTEGRA LIFESCIENCES HLDGS Earnings Preview: Recent $IART Insider Trading, Hedge Fund Activity, and More - Nasdaq
Empowered Funds LLC Takes Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) to Release Earnings on Tuesday - Defense World
SHAREHOLDER ALERT: Morris Kandinov Investigating VG, ADSK, DKS, and IART; Shareholders are Encouraged to Contact the Firm - GlobeNewswire Inc.
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
IART 12-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Integra LifeSciences (IART) Investors with Substantial Losses to Contact the Firm Before Nov. 13th Deadline in Securities Fraud Class Action - ACCESS Newswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences ... - The Bakersfield Californian
Integra LifeSciences (NASDAQ:IART) Shares Down 5.3%What's Next? - MarketBeat
Shareholders in Integra LifeSciences Holdings (NASDAQ:IART) have lost 63%, as stock drops 4.1% this past week - Yahoo Canada Finance
Choreo LLC Acquires 5,123 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences (NASDAQ:IART) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Grabar Law Office is Investigating Claims on Behalf of - GlobeNewswire
Wound Closure Strips Market to Grow by USD 102.8 Million from 2025-2029, Driven by Focus on Reducing SSIs, Report with Market Evolution Powered by AITechnavio - The Malaysian Reserve
EVP, Chief Legal Officer & Sec, Schwartz Eric sold 4,070 shares of Integra Lifesciences Holdings Corp [IART] - Knox Daily
Integra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Down 6.1% in January - MarketBeat
Notice To Long-Term Integra Lifesciences Holdings - GlobeNewswire
Notice To Long-Term Integra Lifesciences Holdings Corporation (NASDAQ: IART) Shareholders: Grabar Law Investigates Claims on Your Behalf - Hamilton Spectator
Ready to Jump After Recent Trade: Integra Lifesciences Holdings Corp (IART) - SETE News
Integra LifeSciences to Release Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 - Yahoo Finance
Global Dental Surgery Instrument Market Regional Analysis [2025-2033] | 107 Pages Modern Report - WICZ
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) PT at $23.00 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Rating of “Reduce” from Brokerages - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Stock Holdings Decreased by Assenagon Asset Management S.A. - Defense World
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):